1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neurological Biomarkers Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neurological Biomarkers by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neurological Biomarkers by Country/Region, 2017, 2022 & 2028

2.2 Neurological Biomarkers Segment by Type

2.2.1 Proteomics

2.2.2 Genomics

2.2.3 Imaging

2.2.4 Bioinformatics

2.2.5 Others

2.3 Neurological Biomarkers Sales by Type

2.3.1 Global Neurological Biomarkers Sales Market Share by Type (2017-2022)

2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neurological Biomarkers Sale Price by Type (2017-2022)

2.4 Neurological Biomarkers Segment by Application

2.4.1 Diagnostics

2.4.2 Drug Discovery

2.4.3 Personalized Medicine

2.4.4 Others

2.5 Neurological Biomarkers Sales by Application

2.5.1 Global Neurological Biomarkers Sale Market Share by Application (2017-2022)

2.5.2 Global Neurological Biomarkers Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neurological Biomarkers Sale Price by Application (2017-2022)

3 Global Neurological Biomarkers by Company

3.1 Global Neurological Biomarkers Breakdown Data by Company

3.1.1 Global Neurological Biomarkers Annual Sales by Company (2020-2022)

3.1.2 Global Neurological Biomarkers Sales Market Share by Company (2020-2022)

3.2 Global Neurological Biomarkers Annual Revenue by Company (2020-2022)

3.2.1 Global Neurological Biomarkers Revenue by Company (2020-2022)

3.2.2 Global Neurological Biomarkers Revenue Market Share by Company (2020-2022)

3.3 Global Neurological Biomarkers Sale Price by Company

3.4 Key Manufacturers Neurological Biomarkers Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neurological Biomarkers Product Location Distribution

3.4.2 Players Neurological Biomarkers Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neurological Biomarkers by Geographic Region

4.1 World Historic Neurological Biomarkers Market Size by Geographic Region (2017-2022)

4.1.1 Global Neurological Biomarkers Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neurological Biomarkers Annual Revenue by Geographic Region

4.2 World Historic Neurological Biomarkers Market Size by Country/Region (2017-2022)

4.2.1 Global Neurological Biomarkers Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neurological Biomarkers Annual Revenue by Country/Region

4.3 Americas Neurological Biomarkers Sales Growth

4.4 APAC Neurological Biomarkers Sales Growth

4.5 Europe Neurological Biomarkers Sales Growth

4.6 Middle East & Africa Neurological Biomarkers Sales Growth

5 Americas

5.1 Americas Neurological Biomarkers Sales by Country

5.1.1 Americas Neurological Biomarkers Sales by Country (2017-2022)

5.1.2 Americas Neurological Biomarkers Revenue by Country (2017-2022)

5.2 Americas Neurological Biomarkers Sales by Type

5.3 Americas Neurological Biomarkers Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neurological Biomarkers Sales by Region

6.1.1 APAC Neurological Biomarkers Sales by Region (2017-2022)

6.1.2 APAC Neurological Biomarkers Revenue by Region (2017-2022)

6.2 APAC Neurological Biomarkers Sales by Type

6.3 APAC Neurological Biomarkers Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neurological Biomarkers by Country

7.1.1 Europe Neurological Biomarkers Sales by Country (2017-2022)

7.1.2 Europe Neurological Biomarkers Revenue by Country (2017-2022)

7.2 Europe Neurological Biomarkers Sales by Type

7.3 Europe Neurological Biomarkers Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neurological Biomarkers by Country

8.1.1 Middle East & Africa Neurological Biomarkers Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neurological Biomarkers Revenue by Country (2017-2022)

8.2 Middle East & Africa Neurological Biomarkers Sales by Type

8.3 Middle East & Africa Neurological Biomarkers Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neurological Biomarkers

10.3 Manufacturing Process Analysis of Neurological Biomarkers

10.4 Industry Chain Structure of Neurological Biomarkers

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neurological Biomarkers Distributors

11.3 Neurological Biomarkers Customer

12 World Forecast Review for Neurological Biomarkers by Geographic Region

12.1 Global Neurological Biomarkers Market Size Forecast by Region

12.1.1 Global Neurological Biomarkers Forecast by Region (2023-2028)

12.1.2 Global Neurological Biomarkers Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neurological Biomarkers Forecast by Type

12.7 Global Neurological Biomarkers Forecast by Application

13 Key Players Analysis

13.1 Thermo Fisher Scientific

13.1.1 Thermo Fisher Scientific Company Information

13.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Offered

13.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Thermo Fisher Scientific Main Business Overview

13.1.5 Thermo Fisher Scientific Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Neurological Biomarkers Product Offered

13.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Quest Diagnostics

13.3.1 Quest Diagnostics Company Information

13.3.2 Quest Diagnostics Neurological Biomarkers Product Offered

13.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Quest Diagnostics Main Business Overview

13.3.5 Quest Diagnostics Latest Developments

13.4 Abbott

13.4.1 Abbott Company Information

13.4.2 Abbott Neurological Biomarkers Product Offered

13.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbott Main Business Overview

13.4.5 Abbott Latest Developments

13.5 Roche

13.5.1 Roche Company Information

13.5.2 Roche Neurological Biomarkers Product Offered

13.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Roche Main Business Overview

13.5.5 Roche Latest Developments

13.6 Illumina

13.6.1 Illumina Company Information

13.6.2 Illumina Neurological Biomarkers Product Offered

13.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Illumina Main Business Overview

13.6.5 Illumina Latest Developments

13.7 Bio-Rad Laboratories

13.7.1 Bio-Rad Laboratories Company Information

13.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Offered

13.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bio-Rad Laboratories Main Business Overview

13.7.5 Bio-Rad Laboratories Latest Developments

13.8 QIAGEN

13.8.1 QIAGEN Company Information

13.8.2 QIAGEN Neurological Biomarkers Product Offered

13.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 QIAGEN Main Business Overview

13.8.5 QIAGEN Latest Developments

13.9 Myriad RBM

13.9.1 Myriad RBM Company Information

13.9.2 Myriad RBM Neurological Biomarkers Product Offered

13.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Myriad RBM Main Business Overview

13.9.5 Myriad RBM Latest Developments

13.10 Cisbio Bioassays

13.10.1 Cisbio Bioassays Company Information

13.10.2 Cisbio Bioassays Neurological Biomarkers Product Offered

13.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Cisbio Bioassays Main Business Overview

13.10.5 Cisbio Bioassays Latest Developments

13.11 Athena Diagnostics

13.11.1 Athena Diagnostics Company Information

13.11.2 Athena Diagnostics Neurological Biomarkers Product Offered

13.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Athena Diagnostics Main Business Overview

13.11.5 Athena Diagnostics Latest Developments

13.12 BGI

13.12.1 BGI Company Information

13.12.2 BGI Neurological Biomarkers Product Offered

13.12.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 BGI Main Business Overview

13.12.5 BGI Latest Developments

13.13 Wuxi APP

13.13.1 Wuxi APP Company Information

13.13.2 Wuxi APP Neurological Biomarkers Product Offered

13.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Wuxi APP Main Business Overview

13.13.5 Wuxi APP Latest Developments

13.14 Aepodia

13.14.1 Aepodia Company Information

13.14.2 Aepodia Neurological Biomarkers Product Offered

13.14.3 Aepodia Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Aepodia Main Business Overview

13.14.5 Aepodia Latest Developments

13.15 Proteome Sciences

13.15.1 Proteome Sciences Company Information

13.15.2 Proteome Sciences Neurological Biomarkers Product Offered

13.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Proteome Sciences Main Business Overview

13.15.5 Proteome Sciences Latest Developments

13.16 Genewiz

13.16.1 Genewiz Company Information

13.16.2 Genewiz Neurological Biomarkers Product Offered

13.16.3 Genewiz Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Genewiz Main Business Overview

13.16.5 Genewiz Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Neurological Biomarkers Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neurological Biomarkers Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Proteomics

Table 4. Major Players of Genomics

Table 5. Major Players of Imaging

Table 6. Major Players of Bioinformatics

Table 7. Major Players of Others

Table 8. Global Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

Table 9. Global Neurological Biomarkers Sales Market Share by Type (2017-2022)

Table 10. Global Neurological Biomarkers Revenue by Type (2017-2022) & ($ million)

Table 11. Global Neurological Biomarkers Revenue Market Share by Type (2017-2022)

Table 12. Global Neurological Biomarkers Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

Table 14. Global Neurological Biomarkers Sales Market Share by Application (2017-2022)

Table 15. Global Neurological Biomarkers Revenue by Application (2017-2022)

Table 16. Global Neurological Biomarkers Revenue Market Share by Application (2017-2022)

Table 17. Global Neurological Biomarkers Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Neurological Biomarkers Sales by Company (2020-2022) & (K Units)

Table 19. Global Neurological Biomarkers Sales Market Share by Company (2020-2022)

Table 20. Global Neurological Biomarkers Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Neurological Biomarkers Revenue Market Share by Company (2020-2022)

Table 22. Global Neurological Biomarkers Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Neurological Biomarkers Producing Area Distribution and Sales Area

Table 24. Players Neurological Biomarkers Products Offered

Table 25. Neurological Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Neurological Biomarkers Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Neurological Biomarkers Sales Market Share Geographic Region (2017-2022)

Table 30. Global Neurological Biomarkers Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Neurological Biomarkers Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Neurological Biomarkers Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Neurological Biomarkers Sales Market Share by Country/Region (2017-2022)

Table 34. Global Neurological Biomarkers Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Neurological Biomarkers Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Neurological Biomarkers Sales by Country (2017-2022) & (K Units)

Table 37. Americas Neurological Biomarkers Sales Market Share by Country (2017-2022)

Table 38. Americas Neurological Biomarkers Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Neurological Biomarkers Revenue Market Share by Country (2017-2022)

Table 40. Americas Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

Table 41. Americas Neurological Biomarkers Sales Market Share by Type (2017-2022)

Table 42. Americas Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

Table 43. Americas Neurological Biomarkers Sales Market Share by Application (2017-2022)

Table 44. APAC Neurological Biomarkers Sales by Region (2017-2022) & (K Units)

Table 45. APAC Neurological Biomarkers Sales Market Share by Region (2017-2022)

Table 46. APAC Neurological Biomarkers Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Neurological Biomarkers Revenue Market Share by Region (2017-2022)

Table 48. APAC Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

Table 49. APAC Neurological Biomarkers Sales Market Share by Type (2017-2022)

Table 50. APAC Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

Table 51. APAC Neurological Biomarkers Sales Market Share by Application (2017-2022)

Table 52. Europe Neurological Biomarkers Sales by Country (2017-2022) & (K Units)

Table 53. Europe Neurological Biomarkers Sales Market Share by Country (2017-2022)

Table 54. Europe Neurological Biomarkers Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Neurological Biomarkers Revenue Market Share by Country (2017-2022)

Table 56. Europe Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

Table 57. Europe Neurological Biomarkers Sales Market Share by Type (2017-2022)

Table 58. Europe Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

Table 59. Europe Neurological Biomarkers Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Neurological Biomarkers Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Neurological Biomarkers Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Neurological Biomarkers Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Neurological Biomarkers Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Neurological Biomarkers Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Neurological Biomarkers Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Neurological Biomarkers

Table 69. Key Market Challenges & Risks of Neurological Biomarkers

Table 70. Key Industry Trends of Neurological Biomarkers

Table 71. Neurological Biomarkers Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Neurological Biomarkers Distributors List

Table 74. Neurological Biomarkers Customer List

Table 75. Global Neurological Biomarkers Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Neurological Biomarkers Sales Market Forecast by Region

Table 77. Global Neurological Biomarkers Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Neurological Biomarkers Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Neurological Biomarkers Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Neurological Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Neurological Biomarkers Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Neurological Biomarkers Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Neurological Biomarkers Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Neurological Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Neurological Biomarkers Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Neurological Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Neurological Biomarkers Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Neurological Biomarkers Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Neurological Biomarkers Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Neurological Biomarkers Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Neurological Biomarkers Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Neurological Biomarkers Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Neurological Biomarkers Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Neurological Biomarkers Revenue Market Share Forecast by Application (2023-2028)

Table 95. Thermo Fisher Scientific Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 96. Thermo Fisher Scientific Neurological Biomarkers Product Offered

Table 97. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Thermo Fisher Scientific Main Business

Table 99. Thermo Fisher Scientific Latest Developments

Table 100. Merck Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 101. Merck Neurological Biomarkers Product Offered

Table 102. Merck Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Merck Main Business

Table 104. Merck Latest Developments

Table 105. Quest Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 106. Quest Diagnostics Neurological Biomarkers Product Offered

Table 107. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Quest Diagnostics Main Business

Table 109. Quest Diagnostics Latest Developments

Table 110. Abbott Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 111. Abbott Neurological Biomarkers Product Offered

Table 112. Abbott Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Abbott Main Business

Table 114. Abbott Latest Developments

Table 115. Roche Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 116. Roche Neurological Biomarkers Product Offered

Table 117. Roche Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Roche Main Business

Table 119. Roche Latest Developments

Table 120. Illumina Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 121. Illumina Neurological Biomarkers Product Offered

Table 122. Illumina Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Illumina Main Business

Table 124. Illumina Latest Developments

Table 125. Bio-Rad Laboratories Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 126. Bio-Rad Laboratories Neurological Biomarkers Product Offered

Table 127. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Bio-Rad Laboratories Main Business

Table 129. Bio-Rad Laboratories Latest Developments

Table 130. QIAGEN Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 131. QIAGEN Neurological Biomarkers Product Offered

Table 132. QIAGEN Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. QIAGEN Main Business

Table 134. QIAGEN Latest Developments

Table 135. Myriad RBM Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 136. Myriad RBM Neurological Biomarkers Product Offered

Table 137. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Myriad RBM Main Business

Table 139. Myriad RBM Latest Developments

Table 140. Cisbio Bioassays Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 141. Cisbio Bioassays Neurological Biomarkers Product Offered

Table 142. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. Cisbio Bioassays Main Business

Table 144. Cisbio Bioassays Latest Developments

Table 145. Athena Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 146. Athena Diagnostics Neurological Biomarkers Product Offered

Table 147. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 148. Athena Diagnostics Main Business

Table 149. Athena Diagnostics Latest Developments

Table 150. BGI Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 151. BGI Neurological Biomarkers Product Offered

Table 152. BGI Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 153. BGI Main Business

Table 154. BGI Latest Developments

Table 155. Wuxi APP Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 156. Wuxi APP Neurological Biomarkers Product Offered

Table 157. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 158. Wuxi APP Main Business

Table 159. Wuxi APP Latest Developments

Table 160. Aepodia Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 161. Aepodia Neurological Biomarkers Product Offered

Table 162. Aepodia Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 163. Aepodia Main Business

Table 164. Aepodia Latest Developments

Table 165. Proteome Sciences Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 166. Proteome Sciences Neurological Biomarkers Product Offered

Table 167. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 168. Proteome Sciences Main Business

Table 169. Proteome Sciences Latest Developments

Table 170. Genewiz Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors

Table 171. Genewiz Neurological Biomarkers Product Offered

Table 172. Genewiz Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 173. Genewiz Main Business

Table 174. Genewiz Latest Developments

List of Figures

Figure 1. Picture of Neurological Biomarkers

Figure 2. Neurological Biomarkers Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neurological Biomarkers Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Neurological Biomarkers Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neurological Biomarkers Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Proteomics

Figure 10. Product Picture of Genomics

Figure 11. Product Picture of Imaging

Figure 12. Product Picture of Bioinformatics

Figure 13. Product Picture of Others

Figure 14. Global Neurological Biomarkers Sales Market Share by Type in 2021

Figure 15. Global Neurological Biomarkers Revenue Market Share by Type (2017-2022)

Figure 16. Neurological Biomarkers Consumed in Diagnostics

Figure 17. Global Neurological Biomarkers Market: Diagnostics (2017-2022) & (K Units)

Figure 18. Neurological Biomarkers Consumed in Drug Discovery

Figure 19. Global Neurological Biomarkers Market: Drug Discovery (2017-2022) & (K Units)

Figure 20. Neurological Biomarkers Consumed in Personalized Medicine

Figure 21. Global Neurological Biomarkers Market: Personalized Medicine (2017-2022) & (K Units)

Figure 22. Neurological Biomarkers Consumed in Others

Figure 23. Global Neurological Biomarkers Market: Others (2017-2022) & (K Units)

Figure 24. Global Neurological Biomarkers Sales Market Share by Application (2017-2022)

Figure 25. Global Neurological Biomarkers Revenue Market Share by Application in 2021

Figure 26. Neurological Biomarkers Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Neurological Biomarkers Revenue Market Share by Company in 2021

Figure 28. Global Neurological Biomarkers Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Neurological Biomarkers Revenue Market Share by Geographic Region in 2021

Figure 30. Global Neurological Biomarkers Sales Market Share by Region (2017-2022)

Figure 31. Global Neurological Biomarkers Revenue Market Share by Country/Region in 2021

Figure 32. Americas Neurological Biomarkers Sales 2017-2022 (K Units)

Figure 33. Americas Neurological Biomarkers Revenue 2017-2022 ($ Millions)

Figure 34. APAC Neurological Biomarkers Sales 2017-2022 (K Units)

Figure 35. APAC Neurological Biomarkers Revenue 2017-2022 ($ Millions)

Figure 36. Europe Neurological Biomarkers Sales 2017-2022 (K Units)

Figure 37. Europe Neurological Biomarkers Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Neurological Biomarkers Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Neurological Biomarkers Revenue 2017-2022 ($ Millions)

Figure 40. Americas Neurological Biomarkers Sales Market Share by Country in 2021

Figure 41. Americas Neurological Biomarkers Revenue Market Share by Country in 2021

Figure 42. United States Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Neurological Biomarkers Sales Market Share by Region in 2021

Figure 47. APAC Neurological Biomarkers Revenue Market Share by Regions in 2021

Figure 48. China Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Neurological Biomarkers Sales Market Share by Country in 2021

Figure 55. Europe Neurological Biomarkers Revenue Market Share by Country in 2021

Figure 56. Germany Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Neurological Biomarkers Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country in 2021

Figure 63. Egypt Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Neurological Biomarkers Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Neurological Biomarkers in 2021

Figure 69. Manufacturing Process Analysis of Neurological Biomarkers

Figure 70. Industry Chain Structure of Neurological Biomarkers

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles